Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine + Palbociclib + Letrozole in ER+/HER2- Breast Cancer
NCT03774472Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2018
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2018; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03774472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774472.